Document Page: First | Prev | Next | All | Image | This Release | Search

SUBJECT:  Sui~~ii~anz~ medical defen~~ against chemi~~tI (CW) and biologwal warfitn-
              (B~~'~ in sLipp()rt o~ Openition 1)1 S ER~ SI-I I l~LD


                                                UNCLASSIFIED

DECLASSIFIED BY DEPSECDEF MEMO 22 MAR q5
DECLASSIFIED ON 9 DEC 96                      I3A~~KGR()UN1) PAPLR
ACTION OFFICER JOHN BUONO LTC USA SP
                                                        ()I'

               NlLi)l( AL DLI I~ NSF ACAJNST CHENlICAL AND BI()LO(1I(~ A~ ~VARFARF

                             JN SL I~P()R~ ()I ()PLRA~~I()N DkSERT SIIJEI~D (U)

          (U) SL'B.IF-&~I

          (U) Sui~~ii~anz~ medical defen~~ against chemi~~tI (CW) and biologwal warfitn-
              (B~~'~ in sLipp()rt o~ Openition 1)1 S ER~ SI-I I l~LD

          (LJ) I)IS( L-SSI()N
               (f;%k; l.!~(!U~~M~~~I   *1~ lRi£AT ln~q has mature ("V and BW program It has used
                                       chcn~ical nervL- and blister agents (mustard) against Iran and the
                                       Kurds  Likely to hav~ w~aponized anthrax and botulinum toxin
                                       Anthrax persistent, hard to control, large area threat Botulinum
                                       toxin lLS5 persistent but effective onlv for small area coverage
                                       (high value targets)

               (U) Nil~DlCAl~ l)L!~LNSl AGAINST Cl-{}.M!CAl WARFARE

                   - (I)) I~rophyl~ixis ~i'icI Antidot~~

                             (~i) P()li~~   Pre'I~ployment issue ()f pyridostigtnin~ (21 tablets) and
                                     atropine and pralidoxim~ autoinjectors (3 of eaeh) k) each individual,
                                     beg n pyndostigni ine prophylaxis upon command dfrection, use
                                     atitoilUectors after exposure, additional antidote supplies st~ieked at
                                     niedical facilities for adni in Istration by medical personnel

                             (U) Antid~~i~ Av~iilabiliiv - i\dequate for DL'sert Shield requirements

                             (U) ~.~~iivuls~'int Antid~~te for Nerve ALTents (CANA) Needed within minutes
                                     of severe nerve agent exposure to prevent or an~eIionite convulsions,
                                     prevent brain damage, decrease recovery lime and decrease mortality,
                                     diazepani (Valium) effeetive adniinistere~1 by medical personnel at
                                     easualty- c~~llecti~~n points (CCPs), autoinjector f~~r individual issue in
                                     pr~~ducti~~n wiih first deliven~es L stimated ()i0 ()r about 26 Sept ()()

                    (S) Casu~ltv l)eco;itamin'
             bi

              bi   - (S) (lollective Pr~~teeti~~n

                    (U) N1ana~'enient of C?.hemic~'il Cisualties  Al~/SG approved guidance issued on
                          emergeney treatment of nerve agent casualties at CCPs and at medical facilitits,
                          aerotnedical evacuation of casualties exposed to ( `V agents, use of CANA by
                          individuals j'nd medical personnel

              - (U) MI~DlCAL Dl~lF.NSL AGAlNS~ l3lQl~XXilCAL `VARI~ARI.

                    (U) Prophvlaxis and Antidotes


                                                L9CLFAPsIi!~~~~/WNINT&

Document Page: First | Prev | Next | All | Image | This Release | Search